Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001567619-21-022453)

Filing Details

Accession Number:: 0001567619-21-022453
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-22 18:21:38
Reporting Period:: 2021-12-20

Accepted Time:: 2021-12-22 18:21:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1733257	Finch Therapeutics Group Inc.	FNCH	Biological Products, (No Disgnostic Substances) (2836)	823433558

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1850404	Nicholas Haft	One Overlook Point, Suite 100 Lincolnshire IL 60060		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value Per Share	Acquisiton	2021-12-20	63,850	$10.18	4,056,907	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Footnotes

All shares are held indirectly by entities of which the reporting person is the manager. The reporting person has voluntarily reported the entire amount of such entities' interest. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any such securities.